MIRM Earnings

Quarterly EPS
$-0.30
Q3 2024
$-0.49
Q4 2024
$-0.30
Q1 2025
$-0.12
Q2 2025
$0.06
Q3 2025
$-0.11
Q4 2025
$-13.43
Q1 2026
$-1.06
Q2 2026
Latest Revenue176.2M
Latest Net Income-67227000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$1.06176.2M-67227000+37.9%-783.3%
Q1 2026-$13.43159.9M-790155000+43.3%-4,376.7%
Q4 2025-$0.11148.9M-5730000+49.8%+77.6%
Q3 2025$0.06133.0M2.9M+47.2%+120.0%
Q2 2025-$0.12127.8M-5861000+64.1%+76.9%
Q1 2025-$0.30111.6M-14677000+61.2%+44.4%
Q4 2024-$0.4999.4M-23790000+42.9%+35.5%
Q3 2024-$0.3090.4M-14235000+89.4%+47.4%
Q2 2024-$0.5277.9M-24638000
Q1 2024-$0.5469.2M-25279000
Q4 2023-$0.7669.6M-35659000
Q3 2023-$0.5747.7M-23588000
Mirum Pharmaceuticals (MIRM) — Earnings